Go Pro

Bicara Therapeutics (BCAX) Institutional Ownership

Bicara Therapeutics logo
$27.76 +0.16 (+0.58%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$27.93 +0.17 (+0.61%)
As of 07/17/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)

Number of
Institutional Buyers
(last 12 months)
76
Total
Institutional Inflows
(last 12 months)
$274.88M
Number of
Institutional Sellers
(last 12 months)
33
Total
Institutional Outflows
(last 12 months)
$56.34M
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE327,989$6.52M0.0%-2.3%0.499%
5/19/2026Janus Henderson Group PLC3,339,218$66.35M0.0%+26.2%5.083%
5/18/2026Rock Springs Capital Management LP489,095$9.73M0.6%+14.0%0.744%
5/16/2026The Manufacturers Life Insurance Company 90,285$1.80M0.0%-8.7%0.137%
5/16/2026Quantinno Capital Management LP17,612$350K0.0%+16.1%0.027%
5/16/2026Orbimed Advisors LLC667,300$13.27M0.2%+219.1%1.016%
5/14/2026Siren L.L.C.5,802,970$115.42M3.2%+11.2%8.833%
5/14/2026Walleye Capital LLC108,008$2.15M0.0%N/A0.164%
5/7/2026Dimensional Fund Advisors LP109,261$2.17M0.0%+166.9%0.167%
5/7/2026Swiss National Bank55,000$1.09M0.0%+70.3%0.084%
5/5/2026Bank of New York Mellon Corp83,264$1.66M0.0%-6.1%0.127%
5/1/2026Candriam S.C.A.238,822$4.75M0.0%N/A0.364%
3/3/2026Caitong International Asset Management Co. Ltd5,775$97K0.0%+385.3%0.011%
2/19/2026T. Rowe Price Investment Management Inc.3,236,595$54.47M0.0%+596.5%5.908%
2/19/2026Invesco Ltd.21,006$354K0.0%+20.6%0.038%
2/18/2026XTX Topco Ltd34,067$573K0.0%-9.8%0.062%
2/18/2026VARCOV Co.15,653$263K0.1%N/A0.029%
2/18/2026Vestal Point Capital LP3,575,000$60.17M2.0%-29.9%6.526%
2/18/2026Virtus Investment Advisers LLC14,395$242K0.1%+46.4%0.026%
2/18/2026Tudor Investment Corp ET AL27,391$461K0.0%+46.2%0.050%
2/18/2026Orbimed Advisors LLC209,100$3.52M0.1%N/A0.382%
2/18/2026Millennium Management LLC434,699$7.32M0.0%-57.2%0.794%
2/18/2026Janus Henderson Group PLC2,646,285$44.48M0.0%N/A4.831%
2/17/2026Trexquant Investment LP37,094$624K0.0%-2.4%0.068%
2/17/2026FIL Ltd758,493$12.77M0.0%-5.6%1.385%
2/17/2026Jump Financial LLC20,988$353K0.0%N/A0.038%
2/17/2026Price T Rowe Associates Inc. MD1,559,535$26.25M0.0%-11.2%2.847%
2/17/2026T. Rowe Price Investment Management Inc.165,243$2.78M0.0%-64.4%0.302%
2/17/2026Rock Springs Capital Management LP429,095$7.22M0.4%+15.8%0.783%
2/17/2026California State Teachers Retirement System17,158$289K0.0%+701.4%0.031%
2/17/2026Russell Investments Group Ltd.56,598$953K0.0%+44.7%0.103%
2/17/2026Graham Capital Management L.P.13,116$221K0.0%N/A0.024%
2/16/2026Mariner LLC64,562$1.09M0.0%+3.0%0.118%
2/16/2026Barclays PLC103,241$1.74M0.0%+114.4%0.188%
2/13/2026The Manufacturers Life Insurance Company 98,918$1.60M0.0%-22.0%0.181%
2/13/2026Hudson Bay Capital Management LP150,000$2.52M0.0%N/A0.274%
2/13/2026Rafferty Asset Management LLC59,819$1.01M0.0%N/A0.109%
2/13/2026Charles Schwab Investment Management Inc.272,145$4.58M0.0%-3.1%0.497%
2/13/2026State Street Corp1,649,537$27.76M0.0%+179.5%3.011%
2/13/2026Wells Fargo & Company MN35,243$593K0.0%+35.9%0.064%
Central banks bought 710 tonnes - this fund pays monthly (Ad)

Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan is now targeting $4,900. One $15 fund is converting gold's momentum into up to $1,152 per month in payouts. No miners, no active trading - just monthly income.tc pixel

See how to collect your first payout before the next surge
2/12/2026HRT Financial LP50,147$843K0.0%N/A0.092%
2/12/2026Dimensional Fund Advisors LP40,934$689K0.0%N/A0.075%
2/12/2026Ensign Peak Advisors Inc401,444$6.76M0.0%N/A0.733%
2/12/2026New York State Common Retirement Fund7,500$126K0.0%+87.5%0.014%
2/12/2026Alps Advisors Inc.44,978$757K0.0%+70.5%0.082%
2/12/2026Swiss National Bank32,300$544K0.0%N/A0.059%
2/12/2026Nuveen LLC38,841$654K0.0%-12.6%0.071%
2/11/2026Deutsche Bank AG128,626$2.17M0.0%+0.9%0.235%
2/11/2026Letko Brosseau & Associates Inc.11,175$188K0.0%N/A0.020%
2/11/2026Franklin Resources Inc.1,620,025$27.27M0.0%N/A2.957%
2/11/2026Clearbridge Investments LLC298,762$5.03M0.0%-7.9%0.545%
2/10/2026TD Asset Management Inc244,626$4.12M0.0%+32.2%0.447%
2/10/2026Goldman Sachs Group Inc.552,331$9.30M0.0%+137.3%1.008%
2/10/2026Norges Bank42,889$722K0.0%N/A0.078%
2/9/2026Geode Capital Management LLC811,400$13.66M0.0%-2.4%1.481%
2/9/2026Bleakley Financial Group LLC29,182$491K0.0%-4.3%0.053%
2/6/2026Atle Fund Management AB111,363$1.87M0.6%-45.3%0.203%
2/4/2026Nan Fung Trinity HK Ltd.372,385$6.27M0.5%-3.2%0.680%
1/29/2026UBS Group AG192,191$3.24M0.0%+97.4%0.351%
1/29/2026China Universal Asset Management Co. Ltd.8,927$150K0.0%N/A0.016%
1/26/2026Mirae Asset Global Investments Co. Ltd.2,662$45K0.0%N/A0.005%
1/12/2026Avanza Fonder AB5,039$85K0.0%-46.2%0.009%
1/9/2026SG Americas Securities LLC11,122$187K0.0%N/A0.020%
1/1/2026JPMorgan Chase & Co.24,935$394K0.0%-9.2%0.046%
1/1/2026Tudor Investment Corp ET AL18,730$296K0.0%N/A0.034%
12/9/2025Tudor Investment Corp ET AL18,730$296K0.0%N/A0.034%
12/1/2025Cantor Fitzgerald L. P.100,000$1.58M0.0%N/A0.183%
11/17/2025XTX Topco Ltd37,774$596K0.0%+16.5%0.069%
11/17/2025Vestal Point Capital LP5,100,000$80.53M3.6%+2.0%9.310%
11/17/2025Mariner LLC62,660$989K0.0%+403.8%0.114%
11/17/2025Millennium Management LLC1,014,892$16.03M0.0%+37.0%1.853%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.16,110$254K0.0%-14.0%0.029%
11/17/2025Larson Financial Group LLC3,949$62K0.0%+1,015.5%0.007%
11/17/2025Jain Global LLC26,179$413K0.0%-77.8%0.048%
11/17/2025Cinctive Capital Management LP41,849$661K0.0%N/A0.076%
11/17/2025Cantor Fitzgerald L. P.100,000$1.58M0.0%N/A0.183%
11/17/2025Bank of America Corp DE456,621$7.21M0.0%+1.2%0.834%
11/17/2025Algert Global LLC17,590$278K0.0%N/A0.032%
11/17/2025Alliancebernstein L.P.40,770$644K0.0%-10.5%0.074%
11/14/2025Creative Planning10,044$159K0.0%N/A0.018%
11/14/2025Schonfeld Strategic Advisors LLC504,085$7.96M0.0%+91.8%0.920%
11/14/2025ADAR1 Capital Management LLC13,705$216K0.0%-40.1%0.025%
11/14/2025Two Sigma Investments LP95,238$1.50M0.0%-29.2%0.174%
11/13/2025UBS Group AG97,362$1.54M0.0%+11.1%0.178%
11/13/2025BNP Paribas Financial Markets36,516$577K0.0%+1,052.7%0.067%
11/13/2025Russell Investments Group Ltd.39,126$618K0.0%+42.4%0.071%
11/13/2025Schroder Investment Management Group173,651$2.74M0.0%-59.2%0.317%
11/12/2025Barclays PLC48,148$760K0.0%-16.0%0.088%
11/12/2025Orion Porfolio Solutions LLC11,303$178K0.0%N/A0.021%
11/12/2025Intech Investment Management LLC14,038$222K0.0%-49.3%0.026%
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
11/10/2025TD Asset Management Inc184,982$2.92M0.0%-17.6%0.339%
11/10/2025Bleakley Financial Group LLC30,478$481K0.0%N/A0.056%
11/7/2025Vanguard Group Inc.2,200,925$34.75M0.0%+9.8%4.030%
11/7/2025JPMorgan Chase & Co.24,935$394K0.0%-9.2%0.046%
11/6/2025Rhumbline Advisers45,619$720K0.0%-2.8%0.084%
11/5/2025Alps Advisors Inc.26,378$417K0.0%-10.3%0.048%
11/4/2025Atle Fund Management AB203,755$3.22M1.3%+38.3%0.373%
11/4/2025Nan Fung Trinity HK Ltd.384,885$6.08M0.6%+12.2%0.705%
11/3/2025New York State Common Retirement Fund4,000$63K0.0%-84.7%0.007%
10/20/2025Ascent Group LLC13,930$220K0.0%N/A0.026%


BCAX Institutional Ownership - Frequently Asked Questions

During the previous two years, 125 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), Siren L.L.C. ($115.42M), Janus Henderson Group PLC ($66.35M), Vestal Point Capital LP ($60.17M), FMR LLC ($57.91M), Red Tree Management LLC ($55.23M), and T. Rowe Price Investment Management Inc. ($54.47M).Learn more on Bicara Therapeutics' institutional investors.

Of the 119 institutional investors that purchased Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), Vestal Point Capital LP ($5.10M), Janus Henderson Group PLC ($4.53M), Red Tree Management LLC ($3.17M), T. Rowe Price Investment Management Inc. ($2.77M), FMR LLC ($2.27M), and Braidwell LP ($2.16M).

Institutional investors have bought a total of 18,071,409 shares in the last 24 months. This purchase volume represents approximately $274.88M in transactions.

Of the 33 institutional investors that sold Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vestal Point Capital LP ($1.53M), Millennium Management LLC ($580.19K), T. Rowe Price Investment Management Inc. ($299.48K), Schroder Investment Management Group ($251.69K), Price T Rowe Associates Inc. MD ($195.88K), Atle Fund Management AB ($92.39K), and Jain Global LLC ($91.73K).

Institutional investors have sold a total of 3,382,668 shares in the last 24 months. This volume of shares sold represents approximately $56.34M in transactions.



This page (NASDAQ:BCAX) was last updated on 7/18/2026 by MarketBeat.com Staff.
From Our Partners